(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol, 95.0%, 10g

3-(2-Methylphenyl)pyrrolidine, 98+%, 1g

methyl 5-bromo-1H-imidazole-2-carboxylate, 95%, 1g

1-Ethyl-4-methylpyridin-1-ium Bromide, 98% HPLC,T, 1g

(S)-3-(2-Fluoro-4-nitrophenoxy)pyrrolidine hydrochloride, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hex-5-enoic acid, 97%, 1g

5-Bromo-2-(cyclobutylmethoxy)pyridine, 1g

2-[(dimethylcarbamothioyl)sulfanyl]acetonitrile, 95%, 5g

tert-Butyl 1,8-diazaspiro[4.5]decane-8-carboxylate hydrochloride, 97%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 97%, 10g

Sodium formate-d, 5g

1-(4-AMINOPHENYL)PYRROLIDIN-2-ONE HCL, 95.0%, 10g

3-Thiophen-2-yl-benzaldehyde, 95.0%, 5g